Oric Pharmaceuticals, Inc. — Director's Dealing 2025

Jan 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oric Pharmaceuticals, Inc. (ORIC)
CIK: 0001796280
Period of Report: 2025-01-02

Reporting Person: Chacko Jacob (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-02	Stock Option (right to buy)	$8.26	A	600000	Acquired	2035-01-01	Common Stock (600000)	Direct
2025-01-02	Restricted Stock Unit	$	A	100000	Acquired		Common Stock (100000)	Direct

Footnotes

F1: 25% of the shares subject to the option shall vest on January 2, 2026, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock.

F3: 1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027.